Ma Yingli, Yue Yang, Ma Yanbin, Zhang Qing, Zhou Qingtong, Song Yunpeng, Shen Yuqing, Li Xun, Ma Xiaochuan, Li Chao, Hanson Michael A, Han Gye Won, Sickmier E Allen, Swaminath Gayathri, Zhao Suwen, Stevens Raymond C, Hu Liaoyuan A, Zhong Wenge, Zhang Mingqiang, Xu Fei
Amgen Asia R&D Center, Amgen Biopharmaceutical R&D (Shanghai) Co., Ltd, Shanghai 201210, China.
iHuman Institute, ShanghaiTech University, 2F Building 6, 99 Haike Road, Pudong New District, Shanghai 201210, China.
Structure. 2017 Jun 6;25(6):858-866.e4. doi: 10.1016/j.str.2017.04.008. Epub 2017 May 18.
Apelin receptor (APJR) is a key regulator of human cardiovascular function and is activated by two different endogenous peptide ligands, apelin and Elabela, each with different isoforms diversified by length and amino acid sequence. Here we report the 2.6-Å resolution crystal structure of human APJR in complex with a designed 17-amino-acid apelin mimetic peptide agonist. The structure reveals that the peptide agonist adopts a lactam constrained curved two-site ligand binding mode. Combined with mutation analysis and molecular dynamics simulations with apelin-13 binding to the wild-type APJR, this structure provides a mechanistic understanding of apelin recognition and binding specificity. Comparison of this structure with that of other peptide receptors suggests that endogenous peptide ligands with a high degree of conformational flexibility may bind and modulate the receptors via a similar two-site binding mechanism.
阿片肽受体(APJR)是人类心血管功能的关键调节因子,可被两种不同的内源性肽配体激活,即阿片肽和埃拉贝拉肽,每种配体都有因长度和氨基酸序列不同而产生的多种异构体。在此,我们报告了与一种设计的17个氨基酸的阿片肽模拟肽激动剂结合的人APJR的2.6埃分辨率晶体结构。该结构表明,肽激动剂采用了内酰胺约束的弯曲双位点配体结合模式。结合突变分析以及阿片肽-13与野生型APJR结合的分子动力学模拟,该结构为阿片肽的识别和结合特异性提供了机制性理解。将该结构与其他肽受体的结构进行比较表明,具有高度构象灵活性的内源性肽配体可能通过类似的双位点结合机制与受体结合并对其进行调节。